lobbying_filings: 2dcbfec3-3c71-467d-a735-5cf3699dc2d6
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | registrant_state | registrant_country | registrant_house_id | client_id | client_name | client_state | client_ppb_state | client_country | client_ppb_country | client_general_description | client_government_entity | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | affiliated_org_count |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2dcbfec3-3c71-467d-a735-5cf3699dc2d6 | RR | 323136 | G2G CONSULTING | OH | US | 39728 | 187183 | LYCERA | MI | MI | US | US | pharmaceutical research and development | 0 | 2011 | first_quarter | 2011-01-11T12:10:42.473000-05:00 | 0 | 0 | 0 | 0 |